Stocktoria

INTELLIGENT BIO SOLUTIONS INC. INBS

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-12-23

INTELLIGENT BIO SOLUTIONS INC. statistics & valuation

P / S1.8×
P / B1.8×
Net margin-346.2%
FCF margin-324.6%
Return on capital-367.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-1676.20% -355.30% -1900.10% -845.90% -326.40% -346.20% 202020212022202320242025
Gross margin (%)
26.00% 45.80% 40.80% 202020212022202320242025
Operating margin (%)
-1513.70% -281.40% -1907.10% -1002.10% -330.50% -348.70% 202020212022202320242025
Return on equity (%)
-46.70% -125.40% -279.90% -121.90% -352.70% 202020212022202320242025
Shares outstanding
8.6M 13.6M 744496 194200 3.5M 5.3M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-127.80% -32.20% -67.20% -102.70% -73.70% -128.10% 202020212022202320242025
Free cash flow margin (%)
-314.70% -324.60% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$11.33 -$127.00 -$6.38 -$2.00 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin40.8%45.8%26.0%
Operating margin-348.7%-330.5%-1002.1%-1907.1%-281.4%-1513.7%
Net margin-346.2%-326.4%-845.9%-1900.1%-355.3%-1676.2%
FCF margin-324.6%-314.7%
Return on assets-128.1%-73.7%-102.7%-67.2%-32.2%-127.8%
Return on equity-352.7%-121.9%-279.9%-125.4%-46.7%60.7%
Current ratio0.771.570.662.334.940.30

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.